Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.2 has been added. Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding/operating status notice as well as the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check78 days agoChange DetectedA government funding notice banner was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check85 days agoChange DetectedUI changes include showing the glossary, adding labels like 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updating the revision tag to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.